Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) EBT: 2012-2024

Historic EBT for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to -$5.4 million.

  • Sunshine Biopharma's EBT fell 3.94% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.5 million, marking a year-over-year decrease of 58.28%. This contributed to the annual value of -$5.4 million for FY2024, which is 30.60% down from last year.
  • As of FY2024, Sunshine Biopharma's EBT stood at -$5.4 million, which was down 30.60% from -$4.1 million recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's EBT peaked at -$2.8 million during FY2020, and registered a low of -$26.5 million during FY2022.
  • Its 3-year average for EBT is -$12.0 million, with a median of -$5.4 million in 2024.
  • As far as peak fluctuations go, Sunshine Biopharma's EBT crashed by 346.70% in 2021, and later soared by 84.49% in 2023.
  • Over the past 5 years, Sunshine Biopharma's EBT (Yearly) stood at -$2.8 million in 2020, then tumbled by 346.70% to -$12.4 million in 2021, then plummeted by 113.17% to -$26.5 million in 2022, then spiked by 84.49% to -$4.1 million in 2023, then crashed by 30.60% to -$5.4 million in 2024.